Invention Grant
- Patent Title: Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines
-
Application No.: US15231182Application Date: 2016-08-08
-
Publication No.: US10004738B2Publication Date: 2018-06-26
- Inventor: Karsten Juhl , Mauro Marigo , Lena Tagmose , Thomas Jensen
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: DK201500456 20150810; DK201500707 20151110
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K45/06 ; A61K31/13 ; A61K31/27 ; A61K31/343 ; A61K31/44 ; A61K31/4433 ; A61K31/4439 ; A61K31/444 ; A61K31/445 ; A61K31/497 ; A61K31/5415 ; A61K31/55
Abstract:
The present invention is directed to the combined use of BACE1 inhibitor of Formula I and a compound useful in active or passive Tau immunotherapy, a compound useful in active or passive Aβ peptide immunotherapy, an NMDA receptor antagonists, an acetylcholine esterase inhibitor, an antiepileptic, an anti-inflammatory drug, a Tau aggregation inhibitor or an SSRI for the treatment of neurodegenerative or cognitive disorders.
Public/Granted literature
- US20170042895A1 Combination Treatment Comprising Administration of 2-Amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines Public/Granted day:2017-02-16
Information query
IPC分类:
